NASDAQ:SGTX
Delisted

Sigilon Therapeutics Stock Signals

etoro logo Buy SGTX
*Your capital is at risk
$22.47
+0 (+0%)
At Close: Nov 09, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Sigilon Therapeutics, Inc.

General

Signal Type Signal Value Data
Score 0.000 117 days ( -209.93 %
Last Price $22.47 0 %
Performance History
7 Days
$22.47 $22.47
0%
30 Days
$22.47 $22.47
0%
12 Mos
$0.471 $22.47
4,667.66%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 20.95
Signal Type Signal Value Importance Data
High / Low N/A Very Low $22.47 - $22.47
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Nov 08, 2023 - 2 days
RSI Short Pivot Signal Buy Very Low Aug 28, 2023 - 52 days
Short MA 3 mos Sell Low Aug 11, 2023 - 63 days
Long MA 3 mos Sell Medium Sep 22, 2023 - 35 days
Short/Long MA 3 mos Sell Medium Sep 22, 2023 - 35 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 65.75
Signal Type Signal Value Importance Data
Trend - 12 mos 1,025.31 % Very High Width: 123.91 %
Pred. range - 12 mos $169.60 - $379.76 High 654.79 % - 1,590.09 %
Short MA 12 mos Sell Very High Aug 31, 2023 - 49 days
Long MA 12 mos Buy Very High May 22, 2023 - 119 days
Short/Long MA 12 mos Buy Very High May 22, 2023 - 119 days
Pivot Long Sell Low Aug 09, 2023 - 65 days
RSI Long Pivot Signal Buy Low Sep 07, 2023 - 45 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT SIGILON THERAPEUTICS, INC.
Sigilon Therapeutics
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neurological manifestations of mucopolysaccharidosis type 1; SIG-007 to provide continuous and prolonged rel...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE